“Zero” Intrinsic Fluorescence Sensing‐Platforms Enable Ultrasensitive Whole Blood Diagnosis and In Vivo Imaging
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202400637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Gangwei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR Chin…. Hauptthemen laut MEDLINE: Optical Imaging, Leucyl Aminopeptidase. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, National Natural Science Foundation of China, National Postdoctoral Program for Innovative Talents.
Abstract (Originalsprache)
Abnormal physiological processes and diseases can lead to content or activity fluctuations of biocomponents in organelles and whole blood. However, precise monitoring of these abnormalities remains extremely challenging due to the insufficient sensitivity and accuracy of available fluorescence probes, which can be attributed to the background fluorescence arising from two sources, 1) biocomponent autofluorescence (BCAF) and 2) probe intrinsic fluorescence (PIF). To overcome these obstacles, we have re‐engineered far‐red to NIR II rhodol derivatives that possess weak BCAF interference. And a series of “zero” PIF sensing‐platforms were created by systematically regulating the open‐loop/spirocyclic forms. Leveraging these advancements, we devised various ultra‐sensitive NIR indicators, achieving substantial fluorescence boosts (190 to 1300‐fold). Among these indicators, 8 ‐LAP demonstrated accurate tracking and quantifying of leucine aminopeptidase (LAP) in whole blood at various stages of tumor metastasis. Furthermore, coupling 8 ‐LAP with an endoplasmic reticulum‐targeting element enabled the detection of ERAP1 activity in HCT116 cells with p53 abnormalities. This delicate design of eliminating PIF provides insights into enhancing the sensitivity and accuracy of existing fluorescence probes toward the detection and imaging of biocomponents in abnormal physiological processes and diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China.
- Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, PR China.
ORCID-Profile: Lin Yuan
Förderung
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- National Natural Science Foundation of China
- National Postdoctoral Program for Innovative Talents
- Science and Technology Program of Hunan Province
Zitieren
APA
Jiang, G., Liu, H., Deng, G., Liu, H., Zhou, Z., Ren, T. B., Wang, L., Zhang, X. B., & Yuan, L. (2024). “Zero” Intrinsic Fluorescence Sensing‐Platforms Enable Ultrasensitive Whole Blood Diagnosis and In Vivo Imaging. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202400637
Vancouver
Jiang G, Liu H, Deng G, Liu H, Zhou Z, Ren TB, et al. “Zero” Intrinsic Fluorescence Sensing‐Platforms Enable Ultrasensitive Whole Blood Diagnosis and In Vivo Imaging. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202400637
BibTeX
@article{Jiang2024,
author = {Jiang, Gangwei and Liu, Hong and Deng, Guohui and Liu, Han and Zhou, Zhixuan and Ren, Tian-Bing and Wang, Lu and Zhang, Xiao-Bing and Yuan, Lin},
title = {“Zero” Intrinsic Fluorescence Sensing‐Platforms Enable Ultrasensitive Whole Blood Diagnosis and In Vivo Imaging},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202400637}
}
EUVIMED